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Conclusions. The reduced expression of p21 and p27, in aReduced p21, p27 and vitamin D receptor in the nodular hyper-
VDR-dependent manner, is a major pathogenic factor for aplasia in patients with advanced secondary hyperparathyroidism.
nodular parathyroid gland growth.Background. In uremic patients with secondary hyperpara-
thyroidism (2HPT), nodular hyperplasia of parathyroid gland
shows a monoclonal pattern of cell proliferation, in which a
decreased density of vitamin D receptor (VDR) also is demon- Many pathogenic factors, including hypocalcemia, phos-strated. The present study aimed at elucidating the mechanism
phate retention, vitamin D deficiency, reduction in theof parathyroid cell proliferation in relation to cell cycle deter-
density of both vitamin D receptor (VDR) and Ca2-minants in patients with advanced 2HPT.
Methods. The expression of cyclin-dependent kinase inhibi- sensing receptor (CaR) in the parathyroid cells, have
tors, p21 and p27, and VDR were examined and compared been reported to participate in the development of sec-
among four groups of nodular (Nd; N  23) or diffuse (Df; ondary hyperparathyroidism (2HPT) in patients withN  6) hyperplastic parathyroid glands resected due to 2HPT,
chronic renal failure [1–3]. Histopathologically, the pat-primary adenomas (Ad; N  15), and histologically-normal
tern of parathyroid hyperplasia in patients with chronicparathyroid glands (C; N 20) removed during thyroidectomy.
Immunohistochemical analyses for VDR, p21, p27 and Ki67 renal failure has been classified as two major patterns:
antigen were performed in formalin-fixed paraffin-embedded diffuse and nodular. In the former, the diffuse parenchy-
tissues by using specific polyclonal antibody. The distribution mal cell proliferation with normal lobular structures isand the intensity of immunoreactivity was quantified by using
the characteristic finding, while the latter is recognizedNIH imaging, and was expressed as the labeling index (LI) of
as the glands exhibiting at least one well-circumscribed,positive nuclear staining in a random set of 1000 cells.
Results. p21 LI was significantly diminished in both Nd (85 encapsulated nodule with virtually fat cell free accumula-
110; mean  SD) and Ad (136  122) as compared to that in tion of parenchymal cells. Based on the investigations
Df (360  191) or C (359  228; P  0.01). p27 LI was also of the relationship between glandular weight and thesignificantly diminished in both Nd (97  156) and Ad (187 
pattern of hyperplasia, it has been reported that nodular196) as compared to that in Df (532  146) or C (631  170;
hyperplasia is usually heavier than hyperplastic parathy-P  0.01). VDR LI in Nd (162  194) was also significantly
lower than that in Df (495 337), Ad (383 262), or C (659 roid glands with a diffuse pattern. It has been considered
234), respectively (P  0.01). Parathyroid sections with high that the hyperplasia may change its growth pattern from
nuclear VDR expression elicited high p21 and p27 expression. diffuse to nodular as the parathyroid gland becomesBoth p21 and p27 LI in Nd correlated significantly with nuclear
heavier [4, 5].VDR LI (r  0.92; P  0.01, r  0.76; P  0.01), but not with
By using image cytometric DNA analyses, a greaterp53 LI, and inversely correlated with the glandular weight (r
0.44; P  0.05, r  0.41; P  0.05). growth is more obvious in the cells of the nodules than
in the surrounding parenchymal cells [6]. Using clonal
analysis with a random inactivation of the X-chromosome-
1 See Editorial by Dusso on p. 1472. linked gene, Tominaga et al found a polyclonal pattern of
cell proliferation in the diffuse hyperplastic parathyroidKey words: uremia, hemodialysis, cyclin-dependent kinase inhibitor,
PTH cell proliferation, parathyroidectomy, cell cycle. glands, whereas there was a distinct monoclonality in
the nodules of nodular hyperplasia [7]. Arnold et al alsoReceived for publication July 16, 2001
reported that 64% of patients who underwent parathy-and in revised form May 22, 2002
Accepted for publication May 28, 2002 roidectomy for advanced renal hyperparathyroidism had
at least one monoclonal parathyroid gland [8]. 2002 by the International Society of Nephrology
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Table 1. Clinical features
Diagnosis N Age years Weight g i-PTH pg/mL Ca mg/dL Pi mg/dL ALP IU/L
Normal 20 5512 NA NA 9.10.4 3.70.5 22056
Hyperplasia N; 23 N; 1.41.6598 1100520 10.70.9 5.71.0 830450(Secondary) D; 6 D; 0.30.2
Adenoma 16 669 1.51.4 280210 11.81.2 2.30.4 400220
Abbreviations are: N, number of specimens; i-PTH, intact parathyroid hormone; Ca, corrected total serum calcium; Pi, inorganic serum phosphate; ALP, alkaline
phosphatase; NA, not available; N, nodular parathyroid hyperplasia; D, diffuse parathyroid hyperplasia. Data are expressed as the meanSD.
The inhibitory effects of calcitriol on 2HPT have been roidectomy with simultaneous autotransplantation for
shown during calcitriol pulse therapy by either oral or severe 2HPT, parathyroidectomy for primary hyperpara-
intravenous administration [9–11], which successfully de- thyroidism with single adenoma, and thyroidectomy for
creased the serum parathyroid hormone (PTH) level. goiter, at Kyushu University between 1995 and 1999.
Furthermore, the antiproliferative effect of calcitriol on Those included 20 normal parathyroid glands as a control
parathyroid glands was shown during oral calcitriol pulse (C), 29 hyperplastic parathyroid glands in 8 patients with
therapy, which successfully decreased the size of hyper- 2HPT, and 16 adenomas (Ad) with primary hyperpara-
plastic parathyroid glands [9]. Kremer et al showed that thyroidism. Histologically, 29 hyperplastic glands were
calcitriol abolished the expression of a protooncogene, diagnosed as having a diffuse pattern (Df) of hyperplasia
c-myc, and delayed the subsequent proliferation of bo- in 6 and a nodular pattern (Nd) of hyperplasia in 23.
vine parathyroid cells in primary culture [12]. However, Hematoxylin and eosin (H&E)-stained sections were re-
the response to calcitriol therapy in nodular hyperplastic viewed independently by two different pathologists (K.T.
glands, which express less VDR density than diffuse hy- and H.H.) for the diagnoses.
perplasia, was reported to be poor as compared to that in
diffuse hyperplasia [2]; the mechanism by which calcitriol Immunohistochemistry
regulates parathyroid cell proliferation via VDR remains All specimens were fixed in 10% formalin and were
unknown. routinely processed to paraffin. Formalin-fixed, paraf-
Liu et al found that p21, a cyclin-dependent kinase fin-embedded tissue sections were serially cut at 4 m
inhibitor (CDKI), is transcriptionally induced by 1,25- and mounted on aminopropyltriethoxysilane-coated glass
dihydroxyvitamin D3 (1,25D) in a VDR-dependent man- slides. These sections were deparaffinized in xylene and
ner, but not a p53-dependent manner, and that p27 also were rehydrated through an ethanol series. The sections
is induced by 1,25D in the myelomonocytic cell line, were treated with 0.1 mol/L citrate, pH 6.0, in an 800-W
U937 [13]. It is known that the p21 and p27 gene codes microwave oven for 15 minutes for antigen retrieval be-
for CDKI regulate the progression from the G1 to the S fore immunohistochemical staining. The sections were
phase of the cell cycle by inhibiting cyclin-dependent pretreated with 5% skim milk at room temperature for
kinase [14–16]. Moreover, a recent publication by Coz- one hour to block nonspecific binding of the primary
zolino and collaborators demonstrated that, in uremic antibodies. The serial sections were then incubated with
rats, the efficacy of 1,25D and its less calcemic analog, the primary antibodies at 4C overnight. Antibodies in-
19-nor-1,25D, to prevent high phosphorus-induced para-
cluded anti-p21 antibody (Santa Cruz Biotechnology, Inc.,
thyroid hyperplasia, could be partially attributed to the
CA, USA) at a 1/100 dilution, anti-p27 antibody (Santainduction of parathyroid p21 expression [17].
Cruz Biotechnology) at a 1/1000 dilution, anti-p53 anti-We hypothesized that the reduced p21 and p27 pro-
body (Novocastra Laboratories Ltd., Newcastle, UK) atduction via the decreased nuclear VDR expression leads
a 1/800 dilution, anti-VDR antibody (Biomeda Labora-to parathyroid cell proliferation in hyperplastic parathy-
tories Ltd., Foster City, CA, USA) at a 1/200 dilutionroid glands, especially nodular hyperplasia. The present
and anti-Ki67 antibody (Novocastra Laboratories) at astudy examined the expressions of VDR, p21, p27, p53,
1/100 dilution. Ki67 antigen is a nuclear protein that isand Ki67 antigen as a proliferation marker to elucidate
expressed in proliferating cells and may be required forthe pathogenic effects of the CDKIs, p21 and p27, on
maintaining cell proliferation. It is expressed in the gran-parathyroid cell proliferation in hemodialysis patients
ular components of the nucleolus during the late G1, S,with advanced 2HPT requiring parathyroidectomy.
G2 and M phases of cell cycle, and has been used as a
marker for cell proliferation of solid tumors. Immuno-
METHODS staining was performed with the Elite avitin biotin perox-
Parathyroid gland tissues idase kit (Nichirei, Tokyo, Japan) according to manufac-
turer’s specifications. Slides were counterstained withThe tissue samples of parathyroid glands were ob-
tained from the patients who underwent total parathy- hematoxylin for two minutes. To demonstrate the speci-
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Fig. 1. Representative microscopic findings of parathyroid gland tissues in each group (H&E stain, 200). (A) Normal parathyroid gland is
composed of chief cells, oxyphilic cells, and stromal fat cells. (B) Parathyroid adenoma is surrounded with compressed rim of normal parathyroid
containing numerous stromal fat cells. (C ) Diffuse parathyroid hyperplasia is characterized by cell proliferation with normal lobular constitution.
(D) Nodular parathyroid hyperplasia is comprised of several nodules surrounded by fibrous capsules.
ficities of primary antibodies used for immunohisto- the nodular area of nodular hyperplasia and did not
include the diffuse area. VDR, p21, p27, p53, and Ki67chemistry, immunohistochemical staining was performed
with a replacement of the first antibody with an equiva- antigen immunoreactive cells were randomly counted
over a minimum of 10 fields. When 10% of parathyroidlent dilution of pre-immune immunoglobulin G or by
pre-absorption of the primary antibodies with the pep- glands were blindly recounted for p21, p27, p53, VDR,
and Ki67 antigen, the LIs did not vary more than  5%tide against which it was raised. For quantitation, all of
the immunohistochemistry was performed with serial from the original count.
sections.
Statistical analysis
Quantitation Data are expressed as the mean  SD. All statistics
were analyzed by using the StatView program (AbacusOnly distinct nuclear immunoreactivity was deemed
positive for VDR, p21, p27, p53, and Ki67 antigen. The Concepts, Berkeley, CA, USA). One-way analysis of
variance (ANOVA) followed by the Student t test withdistribution of immunoreactivity was analyzed by quanti-
fying nuclear staining in randomly selected areas on each Bonferroni correction were used when indicated for
comparison of data among the four groups according tospecimen without knowledge of either diagnosis or out-
come. The number of cells expressing VDR, p21, p27, the histological findings. A linear regression analysis also
was used for the relationship between p21 or p27 LI andp53, and Ki67 antigen were determined by counting a
minimum of 1000 cells per slide using the NIH image either VDR LI, Ki67 LI, gland weight, or p53 LI. A
P value of less than 0.05 was considered statisticallyprogram (NIH, Bethesda, MD, USA). Color images of
10 appropriate locations in each specimen were obtained significant.
at magnification of 20  10, covering an area of 717 
558 m2 using the Fujix digital camera C-300i (Nikon,
RESULTS
Tokyo, USA). The images were then digitized and stored
Clinical characteristics of the patientsusing Photograb 300 version 1.0 (Fuji Photo Film Co.,
Tokyo, Japan) as PICT files. The brightness and contrast Clinical history was recorded and the follow-up infor-
mation for each patient carefully measured, includingof each image were uniformly enhanced or subtracted
by Adobe Photoshop version 4.0 followed by analysis age, preoperative serum level of calcium, inorganic phos-
phorus, alkaline phosphatase and intact parathyroid hor-using the NIH images freeware (version 1.60; available
on the Internet: http://rsb.info.nih.gov/nih-image/download. mone (iPTH) levels; the glandular weight was deter-
mined when either the hyperplastic glands or primaryhtml). The PICT image files were opened in a gray scale
mode by the NIH image software. The plot area, mean adenomas were resected. Indeed, preoperative corrected
serum calcium was highest in the patients with primarydensity and plot number corresponding to positive cell
number were determined using the “Analyze Particles” hyperparathyroidism (11.8  1.2 mg/dL), followed by
those with 2HPT (10.7 0.8 mg/dL) and normal parathy-command after setting a proper threshold, followed by
analysis using Excel v98 (Microsoft Corp., Redmond, roid function (9.1  0.4 mg/dL). Serum inorganic phos-
phorus was highest in the patients with 2HPT (5.7 WA, USA). The threshold was defined in our study as
100 using the “Density Slice” command in the NIH image 1.0 mg/dL), followed by those with normal parathyroid
function (3.7  0.5 mg/dL), primary hyperparathyroid-software. To avoid the influence of non-specific positive
staining, plots of more than 50 pixels were excluded. ism (2.3  0.4 mg/dL). Serum alkaline phosphatase and
iPTH values were higher in patients with 2HPT (834 The number of positive immunoreactive nuclei per 1000
parenchymal cells was expressed as the labeling index 448 IU/L and 1101 515 pg/mL, respectively) than those
with primary hyperparathyroidism (404 222 IU/L, 282(LI). In nodular hyperplasia, cells were counted only in

Fig. 2. Representative immunohistochemical findings of vitamin D receptor (VDR) protein expression in parathyroid gland tissues with diaminoben-
zidine chromogen and hematoxylin counterstain (400). (A) Normal parathyroid gland with nearly all nuclei showing brown staining for VDR
protein. (B) Parathyroid adenoma with some nuclei staining for VDR. (C ) Diffuse parathyroid hyperplasia with the majority of nuclei staining
for VDR. (D) Nodular parathyroid hyperplasia with few nuclei staining for VDR.
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VDR LI and p21 LI was found only in Nd (r  0.92,
P 0.01; Fig. 7). In Nd, the weight of the resected glands
inversely correlated with p21 LI (r  0.44, P  0.05;
Fig. 8).
Expression of VDR and p27 protein
p27 protein expression revealed nuclear localization,
as shown in Figure 9. Semiquantitative analyses revealed
that p27 LI in both Nd (97  156) and Ad (187  196)
were significantly lower as compared to those in C (631
170) and Df (532 146; P 0.01), as shown in Figure 10.
The distributions of VDR and p27 were examined on
Fig. 3. Difference in the mean labeling index (LI) of vitamin D receptor
the serial sections. Parathyroid sections with high nuclear(VDR) protein expression among each histological type of parathyroid
glands. Nodular parathyroid hyperplasia (HP) shows the lowest VDR VDR expression elicited high p27 expression, whereas
LI. *P  0.01 vs. normal; **P  0.01 vs. diffuse HP; ***P  0.01 vs. areas that lacked VDR had no detectable p27 (Fig. 11).
adenoma.
A significant positive correlation between VDR LI and
p27 LI was found only in Nd (r  0.76, P  0.01), as
shown in Figure 12. In Nd, the weight of the resected
glands inversely correlated with p27 LI (r  0.41, P 211 pg/mL, respectively; Table 1). In 2HPT patients, the
average dose of oral alfacalcidol was 0.42  0.23 g/day. 0.05; Fig. 13).
Expression of Ki67 antigenWeight and microscopic findings of the resected glands
The single glandular weight of resected parathyroid A remarkable increase in Ki67 expression was ob-
glands in nodular hyperplasia (1.4 1.6 g) was compara- served in both Ad and Nd, as depicted in Figure 14.
ble with that of primary adenomas (1.5  1.4 g), but it Semiquantitatively, Ki67 LI was significantly higher in
was smaller in diffuse hyperplasia (0.3  0.2 g). Ad (33  27) and Nd (20  18) than in Df (4  4) and
Microscopically, normal parathyroid glands showed C (1  1; P  0.01; Fig. 15). Although the correlation
the constitution of parenchymal cells, such as chief and between Ki67 LI and either p21 or p27 LI was examined
oxiphil cells, with numerous stromal fat cells (Fig. 1A). with serial sections, there was no significant correlation
Ad revealed a remarkably enlarged single nodule with in any histological type of parathyroid glands.
compressed rim of normal parathyroid tissue (Fig. 1B).
Expression of p53 proteinIn Df, the number of parenchymal cells diffusely increased
with normal lobular structure and usually stromal fat Immunohistochemical analyses of p53, as a principal
cells co-existed (Fig. 1C). Nd exhibited well-circum- transcriptional regulator of p21, was performed in each
scribed, encapsulated nodules with virtually fat-free ac- histological type (Fig. 16). NIH image analyses revealed
cumulation of parenchymal cells (Fig. 1D). that p53 LI in Ad of 77  63 was the highest value
among the four groups (P 0.01), and it was comparable
Expression of VDR and p21 protein between other three groups, as shown in Figure 17. Al-
Immunohistochemical staining of VDR protein re- though the correlation between p53 LI and p21 LI was
vealed mainly nuclear localization and, to a lesser degree, examined with serial sections, there was no significant
cytoplasmic localization in each histological type. The correlation in any histological type of parathyroid glands.
representative tissues are shown in Figure 2. Among the
four groups, VDR LI in Nd (162 194) was significantly
DISCUSSIONlower than that in Df (495  337), Ad (383  262), and
The present study demonstrates that the reduced ex-C (659  234), respectively (P  0.01; Fig. 3).
pression of p21 and p27, in association with the decreasedp21 protein expression revealed nuclear localization,
density of VDR, is a major pathogenic feature of theas shown in Figure 4. Semiquantitative analyses showed
nodular hyperplastic parathyroid gland in patients withthat p21 LI in both Nd (85  110) and Ad (136  122)
advanced 2HPT.were significantly lower as compared to those in C (359
Calcitriol reduces parathyroid cell proliferation by de-228) and Df (360  191; P  0.01), as shown in Figure 5.
creasing the expression of the early gene, c-myc [12], theThe distributions of VDR and p21 were examined
gene that modulates the progression from G1 to S phasewith the serial sections. Parathyroid sections with high
in the cell cycle. A decrease in plasma calcitriol and/ornuclear VDR expression elicited high p21 expression,
a disturbance of its action at the level of the parathyroidwhereas the areas that lacked VDR had no detectable
p21 (Fig. 6). A significant positive correlation between cell, which are both frequently observed in uremic pa-
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Fig. 4. Representative immunohistochemical findings of p21 protein expression in parathyroid gland tissues with diaminobenzidine chromogen
and hematoxylin counterstain (400). (A) Normal parathyroid gland. Nearly all nuclei show brown staining for p21 protein. (B) Parathyroid
adenoma. Some nuclei show positive staining for p21. (C ) Diffuse parathyroid hyperplasia. The majority of nuclei show positive staining for p21.
(D ) Nodular parathyroid hyperplasia. Only few nuclei show positive staining for p21.
Fig. 6. Representative immunohistochemical findings of expression of p21 and VDR in serial sections of diffuse hyperplastic parathyroid gland
tissues showing early nodular formation with diaminobenzidine chromogen and hematoxylin counterstain (200). (A) Nuclear VDR expression.
The majority of nuclei are stained strongly with VDR protein in the left side, but only a small number of nuclei show positive staining in the right
side. (B) p21 expression. Immunohistochemistry for p21 expression show positive staining in the nuclei of the left side, which is the same as the
VDR expression.
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Fig. 8. Correlation between the labeling index of p21 expression (p21
LI) and the weight of parathyroid gland only in nodular hyperplasia.
A significant negative correlation was found between p21 LI and the
weight of parathyroid gland in nodular hyperplasia: y  2.0  0.007x;
Fig. 5. Difference in the mean labeling index (LI) of p21 protein ex- r  0.442, P  0.05.
pression among each histological type of parathyroid glands. Nodular
hyperplasia (HP) and adenoma show the lowest p21 LI. *P  0.01 vs.
normal; **P  0.01 vs. diffuse HP.
with previous reports [2]. Therefore, the effects of 1,25D
through its VDR might be limited in nodular hyperplasia.
Parathyroid sections with high nuclear VDR expression
elicited high both p21 and p27 expression, whereas the
areas that lacked VDR had no detectable p21 and p27.
The semiquantitative LI of p21 and p27 significantly cor-
related with that of nuclear VDR, but not with p53,
indicating that p21 and p27 expression in the hyperplastic
parathyroid glands due to 2HPT may be regulated in a
VDR-dependent manner, as reported in the myelomo-
nocytic cell line, U937 [13]. It was reported that p21 and
p27 participate in regulating the transition from the G1
to S phase of the cell cycle [14, 15], and a functional
vitamin D responsive element has been identified in theFig. 7. Correlation between the labeling index of VDR expression
(VDR LI) and that of p21 (p21 LI) only in nodular hyperplasia. A p21 promoter area [13]. Therefore, the suppressive ac-
significant positive correlation is found between VDR LI and p21 LI tion of 1,25D on the cell proliferation also might be
in nodular hyperplasia: y  1.2  0.52x; r  0.915, P  0.01.
diminished in nodular hyperplasia.
Recently, Dusso et al demonstrated the direct effect
of phosphorus on parathyroid cell proliferation in the
early phase of uremia by elegantly designed experimentstients, may cause a lack of inhibition of c-myc expression
done in 5/6 nephrectomized rats [24]. Dietary phospho-and lead to progression of the cell cycle. Calcitriol acti-
rus regulated p21 expression in association with growthvates the p21 gene through a VDR-dependent and p53-
promoter, transforming growth factor-	 (TGF-	). Lowindependent manner, as well as the p27 gene in the mye-
dietary-phosphorus induced p21 expression, whereaslomonocytic cell line, U937 [13]. Moreover, a recent
high phosphorus intake enhanced TGF-	 with a subse-study by Cozzolino and colleagues demonstrates that, in
quent stimulation of parathyroid cell proliferation, inde-uremic rats, the efficacy of 1,25D and its less calcemic
pendent of changes in serum 1,25D. In their study, thereanalog, 19-nor-1,25D, to prevent high phosphorus-induced
was a significant correlation between the decreased p21parathyroid hyperplasia, could partially be attributed to
expression and the enhanced PCNA expression, showingthe induction of parathyroid p21 expression, and the
the direct relationship of p21 with parathyroid cell prolif-increases in p21 correlate inversely with reduced Ki67
eration. Our present study found an important role for[17]. This finding indicates another possible mechanism
p21 and p27 in the parathyroid cell proliferation of pa-by which calcitriol may regulate the proliferation of para-
tients with advanced 2HPT. Although the expression ofthyroid cells.
Ki67 did not correlate with p21 and p27 expression inIn patients with severe 2HPT, hyperplastic parathy-
the present study, Ki67 LI was significantly higher in bothroid glands often show a resistance to the physiological
primary adenomas and nodular hyperplasia, showing aconcentration of serum 1,25D [10, 18–20]. The reason
decreased p21 and p27 expression, than in diffuse hyper-for this resistance is partly explained by VDR deficiency
plasia and normal parathyroid gland. Also, in nodularin the hyperplastic glands [21–23]. In the present study,
hyperplasia, the weight of the resected parathyroidnodular hyperplasia showed a significantly lower VDR
density than diffuse hyperplasia, which is compatible glands inversely correlated with p21 and p27 LI. There-
Fig. 9. Representative immunohistochemical findings of p27 protein expression in parathyroid gland tissues with diaminobenzidine chromogen
and hematoxylin counterstain (400). (A) Normal parathyroid gland. Nearly all nuclei show brown staining for p27 protein. (B) Parathyroid
adenoma. Some nuclei show positive staining for p27. (C ) Diffuse parathyroid hyperplasia. The majority of nuclei show positive staining for p27.
(D ) Nodular parathyroid hyperplasia. Only few nuclei show positive staining for p27.
Fig. 11. Representative immunohistochemical findings p27 and VDR expression in the serial sections of diffuse hyperplastic parathyroid gland
tissues, which show early nodular formation with diaminobenzidine chromogen and hematoxylin counterstain (200). (A) Nuclear VDR expression.
The majority of nuclei are stained strongly with VDR protein expression on the lower side, but only a small number of nuclei show positive
staining in the upper side (200). (B) p27 expression shows positive staining in the nuclei of the lower side, the same as VDR expression.
Tokumoto et al: Cyclin-dependent kinase inhibitors in parathyroid hyperplasia1204
Fig. 10. Differences in the mean labeling index (LI) of p27 protein
expression among each histological type of parathyroid glands. Nodular Fig. 13. Correlation between the labeling index of p27 expression (p27
hyperplasia (HP) and adenoma show the lowest p21 LI. *P  0.01 vs. LI) and the weight of parathyroid gland only in nodular hyperplasia.
normal; **P  0.01 vs. diffuse HP. A significant negative correlation was found between p27 LI and the
weight of parathyroid gland in nodular hyperplasia: y  1.99  0.005x;
r  0.41, P  0.05.
cell proliferation and continuous over-secretion of PTH,
even after achieving a correction of calcium-phosphorus
imbalance.
In the prevention and management of 2HPT, which
results in increased synthesis and secretion of PTH, it is
crucial to understand the mechanisms of regulating cell
growth. Induction of p21 was shown to be sufficient to
induce growth arrest in monocyte-macrophages [13],
keratinocytes [25], and human cancer cells [26], as well
as to suppress tumorigenesis in vivo [27]. Induction ofFig. 12. Correlation between the labeling index of VDR expression
(VDR LI) and that of p27 (p27 LI) only in nodular hyperplasia. A p27 also was demonstrated to be sufficient to induce
significant positive correlation was found between VDR LI and p27 LI growth arrest in monocyte-macrophages [13]. In the hy-
in nodular hyperplasia: y  15.4  0.65x; r  0.76, P  0.01.
perplastic parathyroid glands of patients with 2HPT, ob-
tained most likely by needle biopsy, in situ immunohisto-
chemical analysis of p21 and p27 expression may be a
useful parameter to estimate the response to active vita-fore, our results support a hypothesis that decreased
p21 and p27 expression may lead to parathyroid cell min D therapy, and help assess the decision of surgical
treatment. Up-regulation of parathyroid VDR contentproliferation in advanced 2HPT. Thus, completion of the
cell cycle, induced by the reduced p21 and p27 expression through 1,25D administration may correct parathyroid
VDR and therefore normalize p21 and p27 levels.in a VDR-dependent manner, is suggested to be a major
factor for parathyroid cell proliferation. We focused on the CDKIs, p21 and p27, and VDR as
potential modulators, however, recent studies also haveStimuli for parathyroid cell proliferation include long-
standing hypocalcemia, hyperphosphatemia, and vitamin demonstrated that the several other key regulators in-
cluding c-myc, PRAD1/cyclin D1 and retinoblastomaD deficiency. In the present study, parathyroid sections
with high nuclear VDR expression elicited a high expres- protein (Rb), might be involved in the regulation of
parathyroid cell growth. Based on recent studies, it ission of both p21 and p27, whereas areas lacking VDR
had no detectable p21 and p27. Therefore, among these suggested that cell cycle progression is important for
induction of parathyroid cell proliferation. In nodularfactors, decreased VDR expression accompanied by vita-
min D deficiency may play a major role in parathyroid hyperplastic parathyroid glands, Tominaga et al demon-

Fig. 16. Representative immunohistochemical findings of p53 expression in parathyroid gland tissues with diaminobenzidine chromogen and
hematoxylin counterstain. (A) Normal parathyroid gland where a few nuclei are stained brown for p53 protein. (B) Parathyroid adenoma; the
majority of nuclei show positive staining for p53. (C ) Diffuse parathyroid hyperplasia, showing a few nuclei that have a positive staining for p53.
(D ) Nodular parathyroid hyperplasia where a few nuclei show positive staining for p53, the same as that in the diffuse hyperplasia.
Fig. 14. Immunohistochemical findings of Ki67 antigen in parathyroid gland tissues with diaminobenzidine chromogen and hematoxylin counterstain
(400). (A) Normal parathyroid gland: A few nuclei showed brown staining for Ki67 antigen. (B) Parathyroid adenoma: A majority of the nuclei
showed positive staining for Ki67. (C ) Diffuse parathyroid hyperplasia: In this figure, only 2 nuclei showed positive staining for Ki67. (D) Nodular
parathyroid hyperplasia: Some nuclei showed positive staining for Ki67, but the incidence was less as compared to adenoma.
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Fig. 15. Difference in the mean labeling index of Ki67 expression (Ki67
LI) among each histological type of parathyroid glands. Both adenoma
and nodular hyperplasia (HP) showed a significantly higher ki67 LI.
*P  0.01 vs. normal; **P  0.01 vs. diffuse HP. Fig. 17. Difference in the mean labeling index of p53 expression (p53
LI) among each histological type of parathyroid glands. Parathyroid
adenoma shows the highest p53 LI. Interestingly, no up-regulation of
p53 is found in any of the hyperplastic glands. *P  0.01 vs. normal;
**P  0.01 vs. diffuse hyperplasia (HP); ***P  0.01 vs. nodular HP.
strated that expression of PRAD1/cyclin D1, pRB and
Ki67 antigen was significantly higher than in diffuse hy-
perplastic parathyroid glands [28]. Vasef et al also
showed an overexpression of cyclin D1 protein in human
c-myc [12]. Thus, the vitamin D transcriptional up-regu-hyperplastic parathyroid glands [29]. On the other hand,
lation of the p21 and p27 gene may be one of the mecha-Bianchi et al reported that hypercalcemia suppressed
nisms for the antiproliferative effects of the calcitriol/expression of PRAD1/cyclin D1 in a rat parathyroid cell
VDR complex in blocking the G1-S transition.line [30]. These studies suggest that the higher expression
In our present study, VDR expression also was sub-of PRAD1/cyclin D1 may correlate with a decreased
stantially reduced in parathyroid adenoma, but thereexpression of the calcium sensing receptor (CaR) in nod-
was no significant correlation between either VDR orular hyperplasia. The lack of a cause and effect relation-
glandular weight, and either p21 or p27 expression. Para-ship for the temporal association between increased pro-
thyroid adenomas have substantiated the derangementliferation and reduced expression of CaR has been
in genes thought to be involved primarily in the regula-documented. The studies by Imanishi et al demonstrated
that the reduction in CaR follows rather than determines tion of parathyroid growth, such as the PRAD1/cyclin
the increase in proliferating activity by targeted over- D1 oncogene [34–36] and the MEN1 tumor suppressor
expression of cyclin D1 in parathyroid glands [31]. More- gene [37–39]. Thus, the mechanisms for the decreased
over, similar findings were reported for parathyroid hy- p21 and p27 expression in primary adenomas might be
perplasia in an experimental model of renal failure [32]. different from those in renal hyperplasia. These studies
Thus, it is conceivable that cyclin D1 may play a major and our data suggest that factors other than the reduced
role in parathyroid cell proliferation in uremia. Regard- expression of p21 and p27 contribute to parathyroid cell
ing the control of cyclin D1, in addition to the impact proliferation in primary adenomas.
of 1,25D therapy on parathyroid-p21 expression, Cozzo- In summary, this study demonstrates the higher mito-
lino et al’s study demonstrated evidence of an additional genic properties in nodular hyperplasia in patients with
mechanism for both 1,25D therapy and high dietary cal- advanced 2HPT. It could be attributed to down-regula-
cium to suppress parathyroid growth [17]. These authors tion of the expression of the CDKIs, p21 and p27, in
showed that both 1,25D therapy and high dietary calcium association with the down-regulated expression of VDR
prevent the increases in parathyroid-TGF-	 induced by in the nucleus of parathyroid gland cells. Based on these
renal failure and high dietary phosphorus. Induction of results and the evidence in the literature on the mecha-
cyclin D1 is one of the mechanisms downstream from nisms of action of p21 and p27, we conclude that the
TGF-	 binding to its receptor, the epidermal growth decreased expression of both p21 and p27, in a VDR-
factor receptor, to induce growth [33]. Therefore, the dependent manner, is a major factor for nodular hyper-
reduction of parathyroid TGF-	 caused by two effective plasia, the severest case of 2HPT.
maneuvers to arrest parathyroid gland enlargement in
renal failure could be an important mechanism to down- ACKNOWLEDGMENTS
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